TRIM61
Putative tripartite motif-containing protein 61
Also known as: RNF35, TRI61_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5EBN2
- Gene
- TRIM61
- Ensembl
- ENSG00000183439
- Chromosome
- 4
- Canonical length
- 209 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli fibrillar center,Endoplasmic reticulum
OverviewNCBI Gene
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
209 residues, UniProt reviewed canonical sequence.
>Q5EBN2|TRIM61
1 MEFVTALADL RAEASCPICL DYLKDPVTIS CGHNFCLSCI IMSWKDLHDS FPCPFCHFCC
61 PERKFISNPQ LGSLTEIAKQ LQIRSKKRKR QEEKHVCKKH NQVLTFFCQK DLELLCPRCS
121 LSTDHQHHCV WPIKKAASYH RKKLEEYNAP WKERVELIEK VITMQTRKSL ELKKKMESPS
181 VTRLECSCTI SAHFNLRLPG SSDSSASGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIM61 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 8.3 nTPM
Expression across tissuesHPA
Tissue
- testis: 8.3 nTPM
- thyroid gland: 5.3 nTPM
- ovary: 5 nTPM
- bone marrow: 3.5 nTPM
- adrenal gland: 3.4 nTPM
- fallopian tube: 3.3 nTPM
Single-cell type
- late primary spermatocytes: 143 nCPM
- cardiomyocytes: 78 nCPM
- adipocytes: 27 nCPM
- early spermatids: 23 nCPM
- oocytes: 23 nCPM
- early primary spermatocytes: 13 nCPM
Immune cell
- NK-cell: 8.1 nTPM
- naive B-cell: 5.8 nTPM
- basophil: 5.4 nTPM
- naive CD4 T-cell: 4.4 nTPM
- plasmacytoid DC: 4.1 nTPM
- naive CD8 T-cell: 3.7 nTPM
Brain region
- hypothalamus: 13 nTPM
- midbrain: 12 nTPM
- white matter: 12 nTPM
- medulla oblongata: 12 nTPM
- thalamus: 11 nTPM
- pons: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.04
- DepMap mean gene effect
- -0.31
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIM61 as an antibody target. Whether an autoantibody or antibody against TRIM61 could matter depends on whether native TRIM61 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIM61 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIM61 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...